Table 1.

Demographic and baseline clinical characteristics.^a

	Sham (n = 16)	LiSWT (n = 17)
Age, y	64.6 (52.3–70.2)	67.0 (47.2–69.6)
History of
Diabetes mellitus	3 (18.8)	4 (23.5)
Coronary artery disease	2 (12.5)	1 (5.9)
Hypertension	9 (56.3)	5 (29.4)
Hyperlipidemia	6 (37.5)	6 (35.3)
Low testosterone	4 (25.0)	3 (17.6)
Smoking	4 (25.0)	5 (29.4)
Denies any medical history	3 (18.8)	5 (29.4)
PDE5i response prior to treatment	6 (37.5)	5 (29.4)

Abbreviations: LiSWT, low-intensity shockwave therapy; PDE5i, phosphodiesterase 5 inhibitor.

^aData are presented as median (IQR) or No. (%).